UK The UK country managers of some of the biggest global pharma companies explain what it takes to manage in the UK market. Erik Nordkamp, Pfizer Erik Nordkamp, the Dutch national serving as managing director of Pfizer UK and the newly-appointed president of the ABPI, likens managing a UK affiliate…
Brexit The European Medicines Agency has cut Britain out of its contracts 7 months ahead of Brexit. “You might have been working on a cancer drug for decades and built up so much expertise that you are the absolute specialist in your field and now have to transfer all your knowledge…
Spain With Spain now on the road to economic recovery following the ravages of the global financial crisis, multinational pharmaceutical companies are seeing the country as a top investment destination once more thanks to a much-improved market access scenario, high-quality but affordable manufacturing capabilities and an enviable human resource base. As…
UK With a strong historic footprint in Edinburgh, Canon Medical Systems has based one of its global R&D centres in Scotland from where it develops software for its devices. Ken Sutherland, president, explains how Canon is able to leverage on the talent available in Scotland and what trends he is observing…
Spain Timmo Andersen, general manager of Boehringer Ingelheim in Spain, explains how the affiliate has managed to achieve market-leading growth rates, the challenges and opportunities of the Spanish pharma market, and why BI is investing heavily in a new facility in Spain. Boehringer Ingelheim in Spain grew an impressive 9…
UK Stewart Pearce, managing director of Otsuka UK and Ireland since 2017 discloses how he built up a leadership team fit for the Otsuka of 2023 and highlights what he appreciates about working for a Japanese pharmaceutical company. He says that at Otsuka, people are encouraged to think for themselves, be…
UK Liam O’Toole, CEO of Arthritis Research UK, discusses how arthritis impacts the British economy, raising public awareness of the condition, the potential ramifications of Brexit, and the importance of inter-stakeholder collaboration. What is the social and economic impact of arthritis on the British economy? “We recognize that there is an…
India Dr. Deepak Sawant, Minister of Public Health and Family Welfare in the Government of Maharashtra, provides insights into some crucial achievements with regards to the state’s infant and child mortality rates, the improvement of Maharashtra’s emergency response and ambulance system, and the prevention of oral cancer. While highlighting the state’s…
Baltics As the Lithuanian market matures, profound shifts have been taking place in the arena of human resources and how drug developers go about identifying, acquiring and retaining the personnel they require for a new age of medical science. “There are a number of emerging trends underway that are forcing companies…
Poland Olympus is internationally well-regarded as being a quality camera provider and continues to provide developed countries across the globe with high-tech medical devices from endoscopes to imagery solutions. Tomasz Mrzygłód, managing director of Olympus Poland, sheds light on the company’s long-term vision and how it manifests in Polish work practices,…
Serbia Suzana Djordjevic, director of the Hemofarm Foundation in Serbia, explores the themes of collectivism, social care and how individual acts can have profound outcomes in today’s world. Having enjoyed a colourful career working for NGOs, the media and the Serbian government, Suzana has always allowed her beliefs and passions to…
UK UK pharmaceutical and biotech companies are already finding it increasingly difficult to attract talent from overseas. Additionally, UK firms are looking to poach EMA staff as it heads to Amsterdam from London following Brexit. Following the Brexit vote, the UK is already seeing problems in filling senior positions at life…
See our Cookie Privacy Policy Here